Zhejiang Starry Pharmaceutical Co.,Ltd. Posted 71.9 Million Yuan Net Loss in 2022

Zhejiang Starry Pharmaceutical Co.,Ltd. (浙江司太立制药股份有限公司) (603520.SH) reported a net loss of 71.9 million yuan in 2022, reversing a net profit of 329.8 million yuan for the previous year.

Meanwhile, the company posted 2.1 billion yuan in revenue, up 6.6% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 3.5 billion yuan in total liabilities, with a liability-to-asset ratio of 66.6%.